Year: 2023
Increasing prevalence of cardiovascular diseases is a major factor driving revenue growth of the Vascular Imaging market
Vancouver, Dec. 27, 2023 (GLOBE NEWSWIRE) — The global vascular imaging market size reached USD 5.95 Billion in 2022 and is expected to register a revenue CAGR of 6.5% during the forecast period, according to latest analysis by Emergen Research. Increasing heart disease rates are a major factor driving market revenue growth. Demand for improved vascular imaging technologies has significantly increased owing to increase in prevalence of cardiovascular disorders including atherosclerosis, peripheral artery disease, and aneurysms.
The development of new imaging modalities is another key factor driving deployment of vascular imaging. The ability to visualize and assess vascular structures with greater accuracy and...
Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase
Written by Customer Service on . Posted in Public Companies.
YOKNEAM ILLIT, ISRAEL, Dec. 27, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced a significant increase in the production of its innovative Mudra Band. This strategic move aims to meet the anticipated interest following the Company’s showcase at the upcoming 2024 Consumer Electronic Show (“2024 CES”) event.
Wearable Devices will be showcasing its latest innovations from January 9th to January 12th at the Las Vegas Convention Center, North Hall, Booth #8363 in Las Vegas, Nevada.
Mudra Band: Meeting Demand at 2024 CES
As Wearable Devices gears up for the 2024 CES, the Company is proactively increasing the inventory of its flagship...
Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that Douglas Love, president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 2:15 p.m. PT in San Francisco.
A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.
About Annexon
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company utilizing a distinct scientific approach to stop C1q and...
Swvl Reports First Half 2023 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Positive Operating Cash Flow and Net Profit in H1 2023
DUBAI, United Arab Emirates, Dec. 27, 2023 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a technology provider for enterprise and government mobility solutions with a global footprint, has proudly announced a significant milestone in its financial performance for the first half of the fiscal year 2023. The Company has achieved positive operating cash flow and net profits, which it believes demonstrates the successful completion of the portfolio optimization program initiated last year, off the back of the global economic and capital markets environment at the time. Swvl aims to maintain and further boost profitability while resuming its enhanced strategic expansions to high revenue markets.
Key highlights from Swvl’s H1 2023 financial...
Form 8.3 – [SMART METERING SYSTEMS PLC – 22 12 2023] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
SMART METERING SYSTEMS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position...
Form 8.3 – [abrdn EUROPEAN LOGISTICS INCOME PLC – 22 12 2023] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
abrdn EUROPEAN LOGISTICS INCOME PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date...
Form 8.3 – [YOUNG & CO.’S BREWERY PLC 22 12 2023] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
YOUNG & CO.’S BREWERY PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date...
Puyi Announces Share Exchange Transactions with Certain Shareholders of Fanhua
Written by Customer Service on . Posted in Public Companies.
GUANGZHOU, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — Puyi Inc. (NASDAQ: PUYI) (“Puyi”), a leading third-party wealth management services provider in China, today announced that it has entered into certain share exchange agreements with certain shareholders of Fanhua Inc. (“Fanhua,” NASDAQ: FANH), including Mr. Yinan Hu, co-chairman and CEO of FANHUA, certain executive officers of Fanhua, certain employees of Fanhua and certain other shareholders (collectively “Fanhua’s Participating Shareholders”). The transaction is expected to close on December 29, 2023, subject to customary closing conditions.
Pursuant to the share exchange agreements, Puyi will issue an aggregate of 284,113,314 ordinary shares of Puyi in exchange for an aggregate of 568,226,628 ordinary shares of Fanhua beneficially owned by Fanhua’s Participating Shareholders....
Serstech receives order of 2.9 MSEK from YOUNGJIN SOLUTEC in South Korea
Written by Customer Service on . Posted in Public Companies.
Serstech today received an order of 2.9 MSEK from its partner YOUNGJIN SOLUTEC in South Korea. The order contains instruments and Serstech ChemDash software. The order will be delivered to the Korean National Police Agency (KNPA) and invoiced in the first quarter of 2024.
“KNPA is returning customer and we are honored in their continued trust in our products and in Serstech”, says Serstech CEO Stefan Sandor
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB Phone: +46 739 606 067
Email: ss@serstech.com
or
Thomas Pileby,
Chairman of the Board, Serstech AB Phone: +46 702 072 643
Email: tp@serstech.com
or visit: www.serstech.com
This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact...
Share buybacks in Spar Nord Bank – transactions in week 51
Written by Customer Service on . Posted in Public Companies.
Company announcement no. 75 In company announcement no. 8 2023, Spar Nord announced a share buyback programme of up to DKK 300 million. The share buyback was initiated on 13 February 2023.
The purpose of the share buyback is to reduce the bank’s share capital by the shares acquired under the programme, and the programme is executed pursuant to Regulation (EU) No 596/2014 of 16 April 2014 (“Market Abuse Regulation”).
In week 51 the following transactions were made under the share buyback programme.
Number of shares
Average purchase price
Transaction value (DKK)Accumulated from last announcement
2,625,100
284,749,79618 December 2023
8,000
105.70
845,60019 December 2023
8,000
105.47
843,76020 December 2023
10,000
105.93
1,059,30021 December 2023
9,000
104.57
941,13022 December 2023
9,000
105.14
946,260Total...